Antibiotic Use and Fatal Outcomes among Critically Ill Patients with COVID-19 in Tacna, Peru
Article
[키워드] Acinetobacter
acute renal failure
Adjusted analysis
Anti-bacterial agents
Antibiotics
aRR
Bacteria
Bacterial
Characteristics
Complication
conducted
COVID-19
Critical
Critically ill patient
critically ill patients
Cross-infection
death
Dexamethasone
died
drug resistance
evaluate
evolution of patients
Follow-up
HAI
healthcare
hospital
Hospital mortality
ICU
ICU admission
Ill
incidence
increased risk
Infection
infections
intensive care
IQR
Isolation
median
Mortality
occurred
organism
pandemic
pathogen
Patient
patients evaluated
patients with COVID-19
Peru
proportion
Pseudomonas aeruginosa
required
retrospective cohort study
SARS-CoV-2
significantly
with COVID-19
[DOI] 10.3390/antibiotics10080959 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/antibiotics10080959 PMC 바로가기 [Article Type] Article